Yes but at that time many shareholders were hoping/expecting a cash return upon winning the Mylan arbitration. There will not be any cash forthcoming. I just hope there isn't a CR coming.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025